KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

BioNTech SE (BNTX) Other Non-Current Liabilities (2020 - 2024)

BioNTech SE's Other Non-Current Liabilities history spans 5 years, with the latest figure at $22.3 million for Q4 2024.

  • For Q4 2024, Other Non-Current Liabilities rose 58.45% year-over-year to $22.3 million; the TTM value through Dec 2024 reached $22.3 million, up 58.45%, while the annual FY2024 figure was $22.6 million, 59.63% up from the prior year.
  • Other Non-Current Liabilities for Q4 2024 was $22.3 million at BioNTech SE, up from $14.1 million in the prior quarter.
  • Across five years, Other Non-Current Liabilities topped out at $22.3 million in Q4 2024 and bottomed at $6.6 million in Q4 2020.
  • The 5-year median for Other Non-Current Liabilities is $14.1 million (2023), against an average of $13.3 million.
  • The largest annual shift saw Other Non-Current Liabilities soared 123.3% in 2021 before it plummeted 40.08% in 2022.
  • A 5-year view of Other Non-Current Liabilities shows it stood at $6.6 million in 2020, then skyrocketed by 123.3% to $14.6 million in 2021, then tumbled by 40.08% to $8.8 million in 2022, then soared by 60.64% to $14.1 million in 2023, then surged by 58.45% to $22.3 million in 2024.
  • Per Business Quant, the three most recent readings for BNTX's Other Non-Current Liabilities are $22.3 million (Q4 2024), $14.1 million (Q4 2023), and $8.8 million (Q4 2022).